Is AeroVironment Inc a Buy After Its Latest Earnings Report?

AeroVironment’s fiscal 2026 Q4 revenue more than doubled to $641.6M (vs. $275M a year ago) and net income rose to $63M (from <$17M), with adjusted EPS increasing to $1.84 (from $1.61), all beating consensus ($557M revenue, $1.48 EPS). Backlog surged to $1.2B from under $727M at end-April 2025, supported by BlueHalo and ESAero acquisitions contributing over $282M in quarterly revenue. For fiscal 2027, management guided revenue of ~$2.13B–$2.23B and adjusted EPS of $3.02–$3.34, while the stock was up over 20% in after-hours trading.

Analysis

AVAV is now trading more like a scaled defense platform than a niche drone vendor, which matters because the market typically awards a higher multiple to companies that can turn funded backlog into multi-year visibility. The second-order winner is the broader autonomy/counter-UAS supply chain: avionics, sensors, batteries, and integration software vendors should see tighter demand, while smaller unmanned peers without balance-sheet capacity will struggle to match production and international reach. On a relative basis, this is more threatening to fragmented small-cap defense names than to the large primes.

The near-term risk is that investors confuse revenue acceleration with clean earnings power. Management is explicitly spending against growth, so the next 1-3 quarters will be about margin cadence and working-capital intensity, not just top-line beats; if gross margin or operating leverage stalls, the stock can give back a meaningful chunk of the post-print move. The key falsifier is any sign that funded backlog fails to convert on schedule or that capacity build-out becomes a permanent margin drag rather than a temporary investment cycle.

Contrarian view: the move may be partially overdone because a good share of the upside is already being priced as if M&A, international expansion, and defense demand all compound smoothly. That is not impossible, but it is a demanding setup after a sharp gap higher; the cleaner trade is to buy weakness, not chase the first reaction. If the next earnings cycle shows sequential margin expansion and no integration slippage, the rerating can continue for 6-18 months; if not, AVAV likely reverts toward a more ordinary defense multiple.

Key Decisions for Investors

• AVAV: do not chase the after-hours gap; wait for a 5-8% pullback or a 2-3 day consolidation before initiating a 3-6 month long. Risk/reward is favorable only if entry resets closer to the pre-print breakout zone.
• AVAV Jan/Apr 2027 call spread: buy a modestly out-of-the-money bull call spread instead of stock if you want upside exposure with defined risk; thesis is backlog conversion and capacity ramp, not another immediate 20% reprice.
• Relative value: long AVAV / short XAR for 1-3 months if you expect AVAV to outperform defense beta as the market rewards funded backlog and autonomy exposure. Falsify if sector-wide defense flows drive XAR higher faster than AVAV-specific execution improves.
• Watch item, not trade yet: compare AVAV against KTOS on next sector move; if AVAV’s premium expands without sequential margin improvement, consider fading the relative multiple via a long-KTOS/short-AVAV pair.